Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model

European Journal of Pharmacology

Volumn 440, Issue 1, 2002, Pages 27-35

  Knapp, Richard J ^a,c   Goldenberg, Rachel ^b   Shuck, Caroline ^b   Cecil, Alicia ^b   Watkins, Jeff ^b   Miller, Cortland ^b   Crites, Glenda ^b   Malatynska, Ewa ^b  

^a Cortex Pharmaceuticals Inc ^*  (United States)

^b Indiana University School of Medicine Evansville   (United States)

^c SANOFI   (France)

Author keywords

Affective disorder; Cognition; Glutamate receptor; Nootropic

Indexed keywords

6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; ANIRACETAM; ANTIDEPRESSANT AGENT; CX 731; DESIPRAMINE; DIAZEPAM; FARAMPATOR; FLUOXETINE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE; PIRACETAM; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG WITHDRAWAL; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; COMPETITIVE BEHAVIOR; DESIPRAMINE; DIAZEPAM; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; INJECTIONS, INTRAPERITONEAL; MALE; MAZE LEARNING; MODELS, ANIMAL; NOOTROPIC AGENTS; PIPERIDINES; PIRACETAM; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037023495     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01338-9     Document Type: Article

References (55)

1. Effects of chronic forced swimming and exposure to alarm substance: Physiological and behavioral consequences
2. Effects of a centrally active benzoylpyrrolidine drug on AMPA receptor kinetics
3. Antipredator defensive behaviors in a visible burrow system
4. Life-span studies of dominance and aggression in established colonies of laboratory rats
5. Hippocampal remodeling and damage by corticosteroids: Implications for mood disorders
6. Cognitive function in the affective disorders: A prospective study
7. Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions
8. ECT and non-memory cognition: A review
9. The temporal relationship between depressive symptoms and dementia: A community-based prospective study
10. Comparison of desipramine, amitriptyline, zimeldine and alaproclate in six animal models used to investigate antidepressant drugs
11. A profile of the behavioral changes produced by facilitation of AMPA-type glutamate receptors
12. Stress and glucocorticoids impair retrieval of long-term spatial memory
13. Recent developments in anxiety, stress, and depression
14. Convulsive therapy: A review of the first 55 years
15. Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older
16. The role of amygdala in emotional and feeding behavior of animals
17. Mechanism in maniac-depressive disorders: An evolutionary model
18. Imaging strategies in depression
19. Perspectives on depressive realism: Implications for cognitive theory of depression
20. Facilitative effects of the ampakine CX516 on short-term memory in rats: Enhancement of delayed-nonmatch-to-sample performance
21. Synergistic interactions between ampakines and antipsychotic drugs
22. Comparative studies on antidepressant action of alprazolam in different animal models
23. Influence of antidepressant drugs on learning and memory paradigms in mice
24. Facilitation of olfactory learning by a modulator of AMPA receptors
25. Psychological effects of a drug that facilitates brain AMPA receptors
26. Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans
27. The effect of antidepressant drugs on dominance in rats competing for food
28. Effects of amitriptyline on GABA-stimulated 36Cl-uptake in relation to a behavioral model of depression
29. Reduction of submissive behavior in rats: A test for antidepressant drug activity
30. The brain as a target for adrenocortical steroids: Cognitive implications
31. Aniracetam improves radial maze performance in rats
32. Cognitive dysfunctions in bipolar disorder: Evidence of neuropsychological disturbances
33. Amoxapine and amitriptyline: II. Specificity of cognitive effects during brief treatment of depression
34. Tolerance develops to the spatial learning deficit produced by diazepam in rats
35. Comorbidity of anxiety and unipolar mood disorders
36. Developments of a water-maze procedure for studying spatial learning in the rat
37. The prevalence of depression in Alzheimer's disease and vascular dementia in a population sample
38. Behavioural effects of fluoxetine and tianeptine, two antidepressants with opposite action mechanisms, in rats
39. Cognitive impairments in patients with seasonal affective disorder
40. Some considerations of different modes of action of nootropic drugs
41. Aniracetam augments, and midazolam inhibits, the long-term potentiation in guinea-pig hippocampal slices
42. Different susceptibilities of long-term potentiations in CA3 and CA1 regions of guinea pig hippocampal slices to nootropic drugs
43. Pre-clinical evaluation of cognition enhancing drugs
44. Neurological correlates of depressive symptoms in Alzheimer's disease and vascular dementia
45. Facilitation of glutamate receptors enhances memory
46. Memory functions in depression
47. Animal behavioural studies in the evaluation of antidepressant drugs
48. Cognitive functioning in depression: A review of theory and research
49. The validity of animal models of depression
50. Selective effects of aniracetam across receptor types and forms of synaptic facilitation in hippocampus
51. Depressive symptoms and cognitive decline in nondemented elderly women: A prospective study
52. The effect of imipramine treatment on the predatory dominance in cats
53. Diazepam impairs place learning in native but not in maze-experienced rats in the Morris water maze